Exploring the effect of vitamin D-3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis

Linda Rolf, Anne-Hilde Muris, Amandine Mathias, Renaud Du Pasquier, Inga Koneczny, Giulio Disanto, Jens Kuhle, Sreeram Ramagopalan, Jan Damoiseaux, Joost Smolders, Raymond Hupperts

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1280-1287
Number of pages8
JournalMultiple Sclerosis Journal
Volume24
Issue number10
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • Antibodies
  • EBNA-1
  • Epstein-Barr virus
  • multiple sclerosis
  • supplementation
  • vitamin D
  • EPSTEIN-BARR-VIRUS
  • B-CELL DIFFERENTIATION
  • DISEASE-ACTIVITY
  • RISK
  • PROGRESSION
  • MRI
  • MS

Cite this

Rolf, L., Muris, A-H., Mathias, A., Du Pasquier, R., Koneczny, I., Disanto, G., Kuhle, J., Ramagopalan, S., Damoiseaux, J., Smolders, J., & Hupperts, R. (2018). Exploring the effect of vitamin D-3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 24(10), 1280-1287. https://doi.org/10.1177/1352458517722646